Paul Kraus
Paul Kraus defied expectations for 27 years, becoming the world's longest-living mesothelioma survivor and patient advoc...
Read their story →Understanding Mesothelioma Starts Here
Independent research, treatment information, and advocacy for patients and families facing a mesothelioma diagnosis.
~3,000 Annual U.S. Diagnoses
73% 1-Year Survival Rate
30% Are Veterans
Newly Diagnosed?
Start here. Learn what mesothelioma means for you and your family.
Start here →Treatment Options
Surgery, chemotherapy, immunotherapy, and clinical trials explained.
Explore treatments →Was I Exposed?
Check your occupation, industry, or workplace for asbestos risk.
Assess your risk →Veteran?
1 in 3 mesothelioma patients served. Learn about VA benefits.
VA resources →Latest News
research Baylor-Duke Trial Tests Immunotherapy Plus Chemo Before Mesothelioma Surgery
NEMO trial at Baylor and Duke is recruiting people with operable pleural mesothelioma to test chemoimmunotherapy before surgery.
Feb 13, 2026 BNSF Railway Appeals $8M Libby, Montana Asbestos Verdict Feb 13, 2026 Blood Test Predicts Immunotherapy Response in Operable Mesothelioma Feb 13, 2026 $51M Avon Talc Verdict Upheld in Mesothelioma Case Feb 12, 2026 $34.2M Verdict Against John Crane in Oregon Shipyard Case Feb 12, 2026 Mount Sinai P/D Surgery Achieves Zero Mortality in Mesothelioma Study Feb 12, 2026 See All News →
Featured Interview 
Chris Placitella, Esq.
Trial Attorney, MesoWatch Litigation NetworkChris Placitella is a trial lawyer certified by the New Jersey Supreme Court and shareholder at Cohen, Placitella & Roth, P.C. A nationally recognized authority on mass torts and asbestos litigation, he has served as lead counsel in landmark cases including a $750 million verdict against Johnson & Johnson. Former President of the New Jersey Association for Justice, his work has been featured in the New York Times, Wall Street Journal, and multiple books on corporate litigation.
Watch the Interview → Live Data
Active Clinical Trials
Find mesothelioma clinical trials currently recruiting patients. Data updated automatically from ClinicalTrials.gov.
Browse All Trials → 91 Recruiting
32 Immunotherapy
5 CAR-T Cell
51 U.S. Sites
Updated: Feb 9, 2026
Stories of Survival & Legacy
Steve McQueen and Asbestos Exposure
How Steve McQueen developed mesothelioma from asbestos exposure during Marine Corps service, and what his story reveals ...
Read their story →
Warren Zevon
Warren Zevon's final months remain a powerful example of facing mortality with honesty and creativity after his mesothel...
Read their story →
Stephen Jay Gould
When Stephen Jay Gould was diagnosed with mesothelioma and given 8 months to live, he wrote an essay that still gives ho...
Read their story →
Trial Attorney Chris Placitella on 40 Years Fighting Asbestos Companies
Asbestos trial attorney Chris Placitella discusses 40 years of litigation, what corporations knew, and the talc connecti...
Read their story →
Dr. David Sugarbaker
Dr. David Sugarbaker's contributions to mesothelioma surgery and training continue to shape how the disease is treated w...
Read their story →Mesothelioma By The Numbers
~3,000 Annual U.S. Cases CDC/SEER 2024
73% 1-Year Survival NIH
12% 5-Year Survival SEER
38 years Average Latency CDC
27 Million Workers Were Exposed
Check if your occupation put you at risk for asbestos exposure.
Special Report
The Talcum Powder Cancer Crisis
For decades, millions used talcum powder daily, unaware that some products contained asbestos. Today, over 90,000 lawsuits allege talc caused cancer.
90,000+ Lawsuits Filed
$10B+ In Verdicts
33% Increased Cancer Risk
Timeline: From Warnings to Verdicts
Mesothelioma
From asbestos-contaminated talc. Average verdicts exceed $100 million.
Ovarian Cancer
From genital talc use. Over 50,000 cases filed.
Over $30 Billion in Trust Funds
60+ active asbestos trust funds continue paying claims. Average awards range from $300,000 to $400,000.
Time limits apply. Filing deadlines range from 1-6 years depending on your state.
Recent Verdicts
- $1.56 Billion: J&J Talc, Baltimore (December 2025)
- $966 Million: Mae Moore vs. J&J (2025)
- $750 Million: Four Patients vs. J&J (2020)
Comprehensive Guides
Types of Mesothelioma
Explore Types →Why MesoWatch?
An independent resource for people who need honest answers.
Independent
No law firm owns us. No pharmaceutical company sponsors our content. Every editorial decision starts with one question: does this help people facing a mesothelioma diagnosis?
Comprehensive
271 articles and guides covering diagnosis, treatment, and legal options. 34 occupation profiles and 13 industry guides for people tracing their exposure history.
Current
Our newsroom publishes original reporting on clinical trials, research, and legal developments every week. 122 stories published and growing.
Medically Reviewed
Physicians review every clinical claim on this site. We verify medical information against peer-reviewed research because people making treatment decisions deserve accurate data.